Beyond Carbs: Study Reveals Hidden Factors Impacting Blood Sugar & Insulin Needs in Type 1 Diabetes

The conventional wisdom surrounding Type 1 Diabetes (T1D) treatment – that careful carbohydrate counting is the cornerstone of effective insulin management – is being challenged by new research. A study from the University of Bristol, published in JMIRx Med, reveals that individual insulin needs are far more complex and variable than previously understood, influenced by a range of factors beyond simply how many carbohydrates a person consumes. This finding underscores the limitations of current automated insulin delivery (AID) systems and highlights the urgent need for more personalized approaches to managing this chronic condition.

For the millions worldwide living with T1D, maintaining stable blood glucose levels is a constant balancing act. Type 1 Diabetes is an autoimmune condition where the body’s immune system mistakenly attacks and destroys the insulin-producing cells in the pancreas. The Juvenile Diabetes Research Foundation (JDRF) estimates that over 1.8 million Americans are living with T1D, and millions more globally. Insulin, a hormone crucial for regulating blood sugar, must be administered through injections or an insulin pump. Traditionally, the amount of insulin needed is calculated based on carbohydrate intake, but this approach doesn’t account for the myriad other physiological factors at play.

The Bristol study analyzed data from 29 participants using OpenAPS, a sophisticated, open-source automated insulin delivery system. Researchers discovered that unexpected patterns in insulin requirements were just as common as predictable ones. These unexpected patterns suggest that factors like exercise, hormones, stress, and even circadian rhythms significantly impact glucose levels, often in ways that aren’t easily anticipated or accounted for by current AID systems. The study’s lead author, Isabella Degen from Bristol’s Faculty of Science and Engineering, explained that these findings support the idea that “factors beyond carbohydrates play a substantial role in euglycemia – the state when blood glucose levels are within the standard range.”

The Limits of Current Automated Insulin Delivery Systems

Automated insulin delivery systems represent a significant advancement in T1D management. These systems, which combine a continuous glucose monitor (CGM) and an insulin pump, automatically adjust insulin delivery based on real-time glucose readings. However, the Bristol study suggests that these systems, even as effective, are operating with incomplete information. Without the ability to accurately measure and respond to these less-understood factors, AID systems often err on the side of caution, leading to either hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar).

“However, without measurable information about these factors, AID systems are left to adjust insulin cautiously with the effect of blood glucose levels becoming too low or high,” Degen noted. Hypoglycemia can be particularly dangerous, causing confusion, seizures, and even loss of consciousness. Hyperglycemia, over time, can lead to long-term complications such as heart disease, kidney disease, and nerve damage. The Centers for Disease Control and Prevention (CDC) provides detailed information on recognizing and treating both hypoglycemia and hyperglycemia.

Uncovering Hidden Patterns in Insulin Needs

The researchers employed advanced time series analysis techniques to identify these unexpected patterns in insulin needs. They examined data on insulin on board (IOB), carbohydrates on board (COB), and interstitial glucose (IG) levels, looking for instances where insulin didn’t have the expected effect on glucose levels, or where carbohydrate intake didn’t produce the anticipated rise in blood sugar. The study found that, on average, participants experienced unexpected patterns 13.5 hours per day, highlighting the frequency with which these unpredictable fluctuations occur.

The team is now focused on refining these pattern-finding methods to better handle the complexities of real-world medical data, which often includes irregular sampling and missing data points. Their current work involves developing innovative segmentation and clustering techniques to uncover more granular patterns and improve the accuracy of insulin dosing recommendations. They are also seeking collaborations with experts in time series and machine learning to address the technical challenges associated with analyzing AID data.

The Need for Personalized Treatment Approaches

The findings from the University of Bristol underscore the critical need for personalized treatment approaches in T1D management. The “one-size-fits-all” approach, based solely on carbohydrate counting, is clearly inadequate for many individuals. A more nuanced understanding of the factors influencing insulin needs is essential for optimizing glucose control and minimizing the risk of complications.

To achieve this level of personalization, researchers need access to comprehensive datasets that include a wide range of sensor measurements, beyond just glucose and carbohydrate intake. This could include data on physical activity, stress levels, sleep patterns, hormonal fluctuations, and even environmental factors. The Bristol team is actively seeking long-term, open-access AID datasets to support their research efforts. They emphasize the importance of including a diverse cohort of individuals with T1D to ensure that their findings are generalizable.

Beyond Carbohydrates: What Else Impacts Insulin Needs?

While the Bristol study highlights the complexity of insulin needs, it doesn’t pinpoint all the contributing factors. However, research has identified several key variables that can significantly impact glucose levels. These include:

• Exercise: Physical activity increases insulin sensitivity, meaning the body requires less insulin to process glucose.
• Stress: Stress hormones, such as cortisol, can raise blood sugar levels.
• Hormonal Changes: Fluctuations in hormones, particularly in women during menstruation or pregnancy, can affect insulin requirements.
• Illness: When the body is fighting an infection, insulin needs often increase.
• Sleep: Poor sleep quality can disrupt hormone balance and lead to insulin resistance.
• Temperature: Extreme temperatures can affect insulin absorption.

Understanding how these factors interact with carbohydrate intake is crucial for developing more effective insulin dosing strategies. The challenge lies in accurately measuring and quantifying these variables and integrating them into AID systems.

The Future of T1D Management

The research from the University of Bristol represents a significant step forward in our understanding of T1D. By recognizing the limitations of current approaches and embracing the complexity of individual insulin needs, we can pave the way for more personalized and effective treatments. The development of advanced algorithms and machine learning techniques will be essential for analyzing the vast amounts of data generated by AID systems and identifying patterns that would otherwise head unnoticed.

“Our study highlights that managing Type 1 Diabetes is far more complex than counting carbs,” Degen concluded. “It’s clear that when it comes to diabetes management, one size doesn’t fit all.”

The team’s ongoing work focuses on advancing time series pattern-finding methods to handle the complexities of real-life medical data. They are actively seeking collaborations with time series and machine learning experts to address technical challenges and ultimately drive innovations in personalized care. The next step involves securing larger, more diverse datasets to validate their findings and develop more robust predictive models.

Key Takeaways:

• Current automated insulin delivery systems often fail to account for factors beyond carbohydrate intake.
• Unexpected patterns in insulin needs are common and can lead to fluctuations in blood glucose levels.
• Personalized treatment approaches, tailored to individual physiological factors, are essential for optimal T1D management.
• Further research is needed to identify and quantify the variables that influence insulin requirements.

This research underscores the importance of continued investment in T1D research and the development of innovative technologies to improve the lives of those living with this challenging condition. If you or someone you know is affected by Type 1 Diabetes, resources and support are available through organizations like the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association.

Do you have experience with automated insulin delivery systems? Share your thoughts and experiences in the comments below. And please share this article with anyone who might locate it helpful.